Cargando…

The development of COVID-19 vaccines in the United States: Why and how so fast?

Detalles Bibliográficos
Autores principales: Kuter, Barbara J., Offit, Paul A., Poland, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997594/
https://www.ncbi.nlm.nih.gov/pubmed/33824043
http://dx.doi.org/10.1016/j.vaccine.2021.03.077
_version_ 1783670365433626624
author Kuter, Barbara J.
Offit, Paul A.
Poland, Gregory A.
author_facet Kuter, Barbara J.
Offit, Paul A.
Poland, Gregory A.
author_sort Kuter, Barbara J.
collection PubMed
description
format Online
Article
Text
id pubmed-7997594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79975942021-03-29 The development of COVID-19 vaccines in the United States: Why and how so fast? Kuter, Barbara J. Offit, Paul A. Poland, Gregory A. Vaccine Commentary Elsevier Ltd. 2021-04-28 2021-03-26 /pmc/articles/PMC7997594/ /pubmed/33824043 http://dx.doi.org/10.1016/j.vaccine.2021.03.077 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Kuter, Barbara J.
Offit, Paul A.
Poland, Gregory A.
The development of COVID-19 vaccines in the United States: Why and how so fast?
title The development of COVID-19 vaccines in the United States: Why and how so fast?
title_full The development of COVID-19 vaccines in the United States: Why and how so fast?
title_fullStr The development of COVID-19 vaccines in the United States: Why and how so fast?
title_full_unstemmed The development of COVID-19 vaccines in the United States: Why and how so fast?
title_short The development of COVID-19 vaccines in the United States: Why and how so fast?
title_sort development of covid-19 vaccines in the united states: why and how so fast?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997594/
https://www.ncbi.nlm.nih.gov/pubmed/33824043
http://dx.doi.org/10.1016/j.vaccine.2021.03.077
work_keys_str_mv AT kuterbarbaraj thedevelopmentofcovid19vaccinesintheunitedstateswhyandhowsofast
AT offitpaula thedevelopmentofcovid19vaccinesintheunitedstateswhyandhowsofast
AT polandgregorya thedevelopmentofcovid19vaccinesintheunitedstateswhyandhowsofast
AT kuterbarbaraj developmentofcovid19vaccinesintheunitedstateswhyandhowsofast
AT offitpaula developmentofcovid19vaccinesintheunitedstateswhyandhowsofast
AT polandgregorya developmentofcovid19vaccinesintheunitedstateswhyandhowsofast